SCHEMBL19081699

SCHEMBL19081699

c1ccc2c(c1)ccc1oc3ccc4c5ccc(-c6c7ccccc7c(-c7cccc8oc9ccccc9c78)c7ccccc67)cc5oc4c3c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRKDC P78527 1/20 0.38
ABCG2 Q9UNQ0 3/20 0.34
DUSP3 P51452 1/20 0.34
AHR P35869 4/20 0.34
PAX8 Q06710 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19109891 0.93 ALOX5 (0.42) ALOX5TDP1L3MBTL1PRKDCAHR
SCHEMBL19081445 0.92 ALOX5 (0.38) ALOX5TDP1PRKDCABCG2AHR
SCHEMBL19108535 0.91 ALOX5 (0.41) ALOX5TDP1L3MBTL1PRKDCABCG2
SCHEMBL20127578 0.91 ALOX5 (0.45) ALOX5TDP1L3MBTL1PRKDCABCG2
SCHEMBL17945375 0.91 ALOX5 (0.46) ALOX5L3MBTL1PRKDCAHRMEN1
SCHEMBL17944173 0.91 ALOX5 (0.46) ALOX5L3MBTL1PRKDCAHRMEN1
SCHEMBL23427470 0.90 ALOX5 (0.39) ALOX5TDP1L3MBTL1PRKDCABCG2
SCHEMBL19081700 0.90 TDP1 (0.37) ALOX5TDP1L3MBTL1PRKDCABCG2
SCHEMBL17944078 0.90 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCDUSP3
SCHEMBL17932072 0.90 ALOX5 (0.43) ALOX5TDP1L3MBTL1PRKDCDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885TDP1 2322/4885L3MBTL1 1245/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885TDP1 2322/4885L3MBTL1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.